Lamtex : 1) APPOINTMENT OF NON-EXECUTIVE DIRECTOR 2) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS 3) RE-DESIGNATION OF DIRECTOR 4) CHANGE IN COMPOSITION OF BOARD COMMITTEES

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in Bermuda with limited liability)

(Stock Code: 1041)

1. 1. APPOINTMENT OF NON-EXECUTIVE DIRECTOR
2. APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS
3. 1. 1. RE-DESIGNATIONOF DIRECTOR
   2. CHANGE IN COMPOSITION OF BOARD COMMITTEES

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

The board of directors ("Board") of Lamtex Holdings Limited ("Company") would like to announce that Mr. Sze Ka King ("Mr. Sze") has been appointed by the Board as a non-executive director of the Company with effect from 28 August 2020.

Mr. Sze, aged 32, graduated from the Hong Kong University of Science and Technology in 2010 with a bachelor's degree of Business Administration, major in Professional Accounting and Finance. He then completed his Masters in Management from the London Business School in 2012. From July 2012 to June 2016, he worked at the Securities and Futures Commission of Hong Kong ("SFC") where he started his tenure as a Graduate Trainee and subsequently promoted to Assistant Manager, rotating between departments such as the Licensing Department and the Intermediaries Supervision Department. After he left the SFC, he started building his career as a Compliance Consultant by working at the Compliance Hong Kong Consulting Limited and Alles Compliance Consulting Limited since February 2017 and August 2017 respectively, devoting himself to the handling of various types of application and notifications to the SFC, including but not limited to application for new licence and change of condition. Besides, Mr. Sze, as Compliance Consultant, also provides advice to licensed corporations on an on-going basis.

Save as disclosed above, Mr. Sze (i) does not have any relationship with any directors, senior management, substantial shareholders or controlling shareholders of the Company;

1. does not have any interests in the shares in the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong);

- 1 -

1. does not hold other positions with the Company and its subsidiaries; and (iv) has not held any directorship in any public listed companies in the last three years preceding the date of this announcement or any other major appointments or professional qualifications.

Mr. Sze has entered into a service contract with the Company on 28 August 2020 with no specific term for his appointment, which can be terminated (i) by the Company by giving not less than 1 month's prior notice in writing to Mr. Sze; or (ii) by Mr. Sze by giving not less than 3 months' prior notice in writing to the Company. As a director, he is subject to retirement by rotation and his office can be vacated in accordance with the byelaws of the Company. In particular, Mr. Sze, as appointed by the Board, shall hold office until the next following general meeting of the Company and will be entitled to offer himself for re-election at such meeting. Mr. Sze is entitled to a director's fee of HK$25,000 per month which is determined by arm's length negotiation between the Company and Mr. Sze, with reference to his duties and responsibilities, his qualifications, experiences, the prevailing market conditions and the Company's remuneration policy. Save as disclosed above, there is no information relating to Mr. Sze that is required to be disclosed pursuant to paragraphs (h) to (v) of Rule 13.51(2) of the Rules Governing the Listing of Securities on the Stock Exchange (the "Listing Rules") nor is there any matter about him that needs to be brought to the attention of the shareholders of the Company.

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS

The Board would like to announce that Mr. Cheung Chi Man Dennis ("Mr. Cheung"), Mr. Fung Kim Shun ("Mr. Fung") and Dr. Wen Yanfeng ("Dr. Wen") have been appointed by the Board as independent non-executive directors of the Company with effect from 28 August 2020.

Mr. Cheung

Mr. Cheung, aged 52, is currently an independent non-executive director of the Prosper Construction Holdings Limited, a company listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "Stock Exchange") (stock code: 6816), and also an independent non-executive director, a chairman of the audit committee and a member of each of the remuneration committee and the nomination committee of Sanbase Corporation Limited, a company listed on the GEM of the Stock Exchange (stock code: 8501). Mr. Cheung holds a master's degree in commerce from The University of New South Wales, Australia and a bachelor's degree in mechanical engineering from Imperial College, London, the United Kingdom. He is a fellow member of The Hong Kong Institute of Certified Public Accountants and a certified tax adviser of The Taxation Institute of Hong Kong. Mr. Cheung has over 20 years' experience in financial management, treasury and company secretarial matters. He was appointed as an independent non-executive director of New Western Group Limited (formerly known as Megalogic Technology Holdings Limited), a company listed on the GEM of the Stock Exchange (stock code: 8242), between April 2015 and May 2020.

- 2 -

Save as disclosed above, Mr. Cheung (i) does not have any relationship with any directors, senior management, substantial shareholders or controlling shareholders of the Company;

1. does not have any interests in the shares in the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong);
2. does not hold other positions with the Company and its subsidiaries; and (iv) has not held any directorship in any public listed companies in the last three years preceding the date of this announcement or any other major appointments or professional qualifications.

Mr. Cheung has entered into a service contract with the Company on 28 August 2020 with no specific term for his appointment, which can be terminated (i) by the Company by giving not less than 1 month's prior notice in writing to Mr. Cheung; or (ii) by Mr. Cheung by giving not less than 3 months' prior notice in writing to the Company. As a director, he is subject to retirement by rotation and his office can be vacated in accordance with the bye-laws of the Company. In particular, Mr. Cheung, as appointed by the Board, shall hold office until the next following general meeting of the Company and will be entitled to offer himself for re-election at such meeting. Mr. Cheung is entitled to a director's fee of HK$25,000 per month which is determined by arm's length negotiation between the Company and Mr. Cheung, with reference to his duties and responsibilities, his qualifications, experiences, the prevailing market conditions and the Company's remuneration policy. Save as disclosed above, he did not hold any directorship in other listed public companies in the past three years or any position within the Group. Save as disclosed above, there is no information relating to Mr. Cheung that is required to be disclosed pursuant to paragraphs (h) to (v) of Rule 13.51(2) of the Listing Rules nor is there any matter about him that needs to be brought to the attention of the shareholders of the Company

Mr. Fung

Mr. Fung, aged 52, serves as Deputy Secretary-General of Zhang Xueliang Foundation and Honorary Advisor of Hong Kong Chaodai Guo Clan Association.

Mr. Fung served in the Hong Kong Police Force for 19 years. He graduated from the Special Criminal Investigation Training School in May 1997 and completed the basic oral swab sampling course at the Hong Kong Government Laboratory in June 2003. Mr. Fung mainly worked in the police force, including intelligence group, serious crime group and anti-triad group.

Save as disclosed above, Mr. Fung (i) does not have any relationship with any directors, senior management, substantial shareholders or controlling shareholders of the Company;

1. does not have any interests in the shares in the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong);
2. does not hold other positions with the Company and its subsidiaries; and (iv) has not held any directorship in any public listed companies in the last three years preceding the date of this announcement or any other major appointments or professional qualifications.

- 3 -

Mr. Fung has entered into a service contract with the Company on 28 August 2020 with no specific term for his appointment, which can be terminated (i) by the Company by giving not less than 1 month's prior notice in writing to Mr. Fung; or (ii) by Mr. Fung by giving not less than 3 months' prior notice in writing to the Company. As a director, he is subject to retirement by rotation and his office can be vacated in accordance with the bye-laws of the Company. In particular, Mr. Fung, as appointed by the Board, shall hold office until the next following general meeting of the Company and will be entitled to offer himself for re-election at such meeting. Mr. Fung is entitled to a director's fee of HK$25,000 per month which is determined by arm's length negotiation between the Company and Mr. Fung, with reference to his duties and responsibilities, his qualifications, experiences, the prevailing market conditions and the Company's remuneration policy. Save as disclosed above, he did not hold any directorship in other listed public companies in the past three years or any position within the Group. Save as disclosed above, there is no information relating to Mr. Fung that is required to be disclosed pursuant to paragraphs

1. to (v) of Rule 13.51(2) of the Listing Rules nor is there any matter about him that needs to be brought to the attention of the shareholders of the Company.

Dr. Wen

Dr. Wen, aged 40, has a bachelor's degree in economics, a master's degree in law and a doctoral degree in procedural law at Renmin University of China Law School. He is also the director of the Institute of Financial Securities Litigation of the Litigation Case Research Center of the People's University of China, a visiting scholar of the Law School of the University of Hong Kong, mediator of Shenzhen Securities and Futures Dispute Mediation Center, and member of Shenzhen Intellectual Property Expert Committee.

Dr. Wen had served as deputy chief of the economic crime investigation bureau of Shenzhen Public Security Bureau. He has been engaged in economic crime investigation for more than 14 years, with rich legal practice experience in financial securities, intellectual property rights, criminal compliance, tax compliance, criminal and civil, criminal and administrative intersection. He has dealt with major financial cases such as the Southern Securities case, China Merchants Securities case, Aokangde Lianxing (奥康德連興) company's major foreign exchange fraud case, and has handled cases involving infringement of intellectual property rights of Huawei, ZTE, Microsoft, Intel, Apple, Samsung and other well-known companies. On behalf of the Shenzhen municipal government, he edited the Summary of 40 years' Intellectual Property Classic Cases in Shenzhen Special Economic Zone.

Dr. Wen is familiar with the supervision and operation logic of socialist market economy, and has strong ability to control commercial and legal risks. Under the national laws and

regulations and the general policies, Dr. Wen Yanfeng took the lead in the establishment of Pule Investment Holding (Shenzhen) Co., Ltd. (朴樂投資控股（深圳）有限公司) and

served as the chairman of the board. The company is committed to the investment, M&A and industrial capital operation of health care industry, new materials for health and epidemic prevention, energy development, agricultural and leisure towns, etc. At the

- 4 -

same time, he is a Senior Chief Councillor of a law firm that committed to the fields of financial securities, investment and merger, intellectual property rights, disposal of non- performing assets, criminal compliance and defense. Its clients include China Aerospace Science and engineering, China National Building Materials, China Railway Construction Engineering, CGN, China Resources Property, China Resources Bank, Ping An Lufax, Tencent, Mindray Medical, HNA Air & Shipping Exchange, TCL Electronics, Kaisa Group and other well-known companies.

Save as disclosed above, Dr. Wen (i) does not have any relationship with any directors, senior management, substantial shareholders or controlling shareholders of the Company;

1. does not have any interests in the shares in the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong);
2. does not hold other positions with the Company and its subsidiaries; and (iv) has not held any directorship in any public listed companies in the last three years preceding the date of this announcement or any other major appointments or professional qualifications

Dr. Wen has entered into a service contract with the Company on 28 August 2020 with no specific term for his appointment, which can be terminated (i) by the Company by giving not less than 1 month's prior notice in writing to Dr. Wen; or (ii) by Dr. Wen by giving not less than 3 months' prior notice in writing to the Company. As a director, he is subject to retirement by rotation and his office can be vacated in accordance with the bye-laws of the Company. In particular, Dr. Wen, as appointed by the Board, shall hold office until the next following general meeting of the Company and will be entitled to offer himself for re-election at such meeting. Dr. Wen is entitled to a director's fee of HK$25,000 per month which is determined by arm's length negotiation between the Company and Dr. Wen, with reference to his duties and responsibilities, his qualifications, experiences, the prevailing market conditions and the Company's remuneration policy.

Save as disclosed above, he did not hold any directorship in other listed public companies in the past three years or any position within the Group. Save as disclosed above, there is no information relating to Dr. Wen that is required to be disclosed pursuant to paragraphs

1. to (v) of Rule 13.51(2) of the Listing Rules nor is there any matter about him that needs to be brought to the attention of the shareholders of the Company.

Following the appointment of Mr. Cheung, Mr. Fung and Dr. Wen, the Board now comprises of three independent non-executive Directors, the audit committee now comprises of three members, the remuneration committee now comprises of chaired by an independent non-executive director and comprising a majority of independent non-executive directors and the nomination committee now comprised a majority of independent non-executive directors. The Company is in compliance with Rule 3.10, Rule 3.21 and Rule 3.25 of the Listing Rules and code provision A.5.1 of the Corporate Governance Code contained in Appendix 14 to the Listing Rules.

- 5 -

RE-DESIGNATION OF DIRECTOR

The Board would like to announce that with effect from 28 August 2020 Mr. Liu Kam Lung ("Mr. Liu") has been re-designated from an independent non-executive Director to an executive Director.

Mr. Liu, aged 56, has over 29 years of experience in the financial industry. Mr. Liu obtained a Diploma of Business Administration from Hong Kong Shue Yan College (now known as Hong Kong Shue Yan University) in 1990. Mr. Liu was admitted as an associate of The Institute of Chartered Secretaries and Administrators of the United Kingdom, an associate of The Hong Kong Institute of Chartered Secretaries, an associate of Hong Kong Institute of Certified Public Accountants, a fellow of The Association of Chartered Certified Accountants, a full member of the Society of Registered Financial Planners and an associate of the Taxation Institute of Hong Kong in 1993, 1994, 1995, 1999, 2009 and 2010 respectively.

Mr. Liu is currently the chief executive officer of China Rise Finance Group Company Limited, being a member of Symphony Holdings Limited (HK stock code: 1223). Mr. Liu had been a non-executive director of New Western Group Limited (HK stock code: 8242) during the period from 16 October 2014 to 2 June 2020, an independent non-executive director of Pak Tak International Limited (HK stock code: 2668) during the period from 24 September 2014 to 1 October 2019, and an independent non-executive director of Enterprise Development Holdings Limited (HK stock code: 1808) during the period from 28 January 2015 to 27 April 2017.

Save as disclosed above, Mr. Liu (i) does not have any relationship with any directors, senior management, substantial shareholders or controlling shareholders of the Company;

1. does not have any interests in the shares in the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong);
2. does not hold other positions with the Company and its subsidiaries; and (iv) has not held any directorship in any public listed companies in the last three years preceding the date of this announcement or any other major appointments or professional qualifications.

Mr. Liu has entered into a service contract with the Company on 28 August 2020, which can be terminated (i) by the Company by giving not less than 1 month's prior notice in writing to Mr. Liu; or (ii) by Mr. Liu by giving not less than 1 month's prior notice in writing to the Company. As a director, he is subject to retirement by rotation and his office can be vacated in accordance with the bye-laws of the Company.

In particular, Mr. Liu, as appointed by the Board, shall hold office until the next following general meeting of the Company and will be entitled to offer himself for re-election at such meeting. Mr. Liu is entitled to a director's fee of HK$120,000 per month which is determined by arm's length negotiation between the Company and Mr. Liu, with reference to his duties and responsibilities, his qualifications, experiences, the prevailing market conditions and the Company's remuneration policy. Save as disclosed above, there is no

- 6 -

information relating to Mr. Liu that is required to be disclosed pursuant to paragraphs (h) to (v) of Rule 13.51(2) of the Listing Rules nor is there any matter about him that needs to be brought to the attention of the shareholders of the Company.

CHANGE IN COMPOSITION OF BOARD COMMITTEES

The Board would like to announce that with effect from 28 August 2020:

Remuneration Committee

Mr. Liu ceased to be the member of the remuneration committee of the Company. Mr. Cheung has been appointed as the chairman and Mr. Fung and Dr. Wen have been appointed as members of the remuneration committee of the Company.

Nomination Committee

Mr. Liu ceased to be the member of the nomination committee of the Company. Mr. Cheung, Mr. Fung and Dr. Wen have been appointed as members of the nomination committee of the Company.

Audit Committee

Mr. Liu ceased to be the chairman of the audit committee of the Company. Mr. Cheung has been appointed as the chairman and Mr. Fung and Dr. Wen have been appointed as members of the audit committee of the Company.

The Board would like to express its warm welcome to Mr. Sze, Mr. Cheung, Mr. Fung and Dr. Wen on their appointments.

By Order of the Board

Lamtex Holdings Limited

Huang Bin

Chairman and Executive Director

Hong Kong, 28 August 2020

As at the date of this announcement, the Board comprises three Executive Directors, namely Mr. Huang Bin, Mr. Wu Xiaolin and Mr. Liu Kam Lung; three Non-Executive Directors, namely Ms. Zang Yanxia, Mr. Pan Xian and Mr. Sze Ka King; and four Independent Non-Executive Directors, namely Mr. Li Changhui, Mr. Cheung Chi Man Dennis, Mr. Fung Kim Shun and Dr. Wen Yanfeng.

- 7 -